Caricamento...
Development of a High-Throughput Homogeneous AlphaLISA Drug Screening Assay for the Detection of SARS-CoV-2 Nucleocapsid
[Image: see text] The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is in urgent need of therapeutic options. High-throughput screening (HTS) offers an opportunity to rapidly identify such compounds. In this work, we have develope...
Salvato in:
| Pubblicato in: | ACS Pharmacol Transl Sci |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American
Chemical Society
2020
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7553038/ https://ncbi.nlm.nih.gov/pubmed/33330840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsptsci.0c00122 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|